EUR-Lex & EU Commission AI-Powered Semantic Search Engine
Modern Legal
  • Query in any language with multilingual search
  • Access EUR-Lex and EU Commission case law
  • See relevant paragraphs highlighted instantly
Start free trial

Similar Documents

Explore similar documents to your case.

We Found Similar Cases for You

Sign up for free to view them and see the most relevant paragraphs highlighted.

Case C-721/24, Vista-Life Pharma and Vista-Life Pharma Belgium: Request for a preliminary ruling from the Cour d’appel de Bruxelles (Belgium) lodged on 22 October 2024 – Vista-Life Pharma SA, Vista-Life Pharma Belgium SCRL v Laboratoires S.M.B. SA, Brussels Reps Pharma SRL

ECLI:EU:UNKNOWN:62024CN0721

62024CN0721

October 22, 2024
With Google you find a lot.
With us you find everything. Try it now!

I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!

Valentina R., lawyer

Official Journal of the European Union

EN

C series

C/2025/708

10.2.2025

(Case C-721/24, Vista-Life Pharma and Vista-Life Pharma Belgium)

(C/2025/708)

Language of the case: French

Referring court

Parties to the main proceedings

Appellants: Vista-Life Pharma SA, Vista-Life Pharma Belgium SCRL

Respondents: Laboratoires S.M.B. SA, Brussels Reps Pharma SRL

Questions referred

1.Is Article 2(2)(1) and (5) of Regulation No 1924/2006 to be interpreted as meaning that the expressions ‘particular characteristics’ and ‘a food category, a food or one of its constituents’ cover statements relating to the frequency of intake and/or the route of administration of the foodstuff?

2.Is Article 14(2) of Regulation No 1924/2006 to be interpreted as requiring the labelling or, if no such labelling exists, the presentation or advertising to reproduce verbatim the statement indicating that the disease to which the claim is referring ‘has multiple risk factors and … altering one of these risk factors may or may not have a beneficial effect’?

3.Is Article 14(2) of Regulation No 1924/2006 to be interpreted as requiring that advertising which contains the reduction of disease risk claim must include the statement indicating that ‘the disease to which the claim is referring has multiple risk factors and that altering one of these risk factors may or may not have a beneficial effect’ where that statement appears on the packaging, leaflet and/or website of the product?

Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods (OJ 2006 L 404, p. 9).

ELI: http://data.europa.eu/eli/C/2025/708/oj

ISSN 1977-091X (electronic edition)

EurLex Case Law

AI-Powered Case Law Search

Query in any language with multilingual search
Access EUR-Lex and EU Commission case law
See relevant paragraphs highlighted instantly

Get Instant Answers to Your Legal Questions

Cancel your subscription anytime, no questions asked.Start 14-Day Free Trial

At Modern Legal, we’re building the world’s best search engine for legal professionals. Access EU and global case law with AI-powered precision, saving you time and delivering relevant insights instantly.

Contact Us

Tivolska cesta 48, 1000 Ljubljana, Slovenia